Compare ARCT & GNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARCT | GNT |
|---|---|---|
| Founded | 2013 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 163.4M | 153.6M |
| IPO Year | 2019 | N/A |
| Metric | ARCT | GNT |
|---|---|---|
| Price | $15.29 | $9.14 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $24.11 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 57.7K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.61% |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ 0.95 |
| Revenue | ★ $82,031,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.77 | N/A |
| P/E Ratio | ★ N/A | $9.56 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.50 | $6.68 |
| 52 Week High | $24.14 | $9.38 |
| Indicator | ARCT | GNT |
|---|---|---|
| Relative Strength Index (RSI) | 61.83 | 51.48 |
| Support Level | $6.47 | $7.81 |
| Resistance Level | $17.75 | $9.06 |
| Average True Range (ATR) | 1.38 | 0.12 |
| MACD | -0.30 | -0.05 |
| Stochastic Oscillator | 36.23 | 0.00 |
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
GAMCO Natural Resources, Gold & Income Trust is a non-diversified closed-end management investment company. The company's primary investment objective is to provide a high level of current income from interest, dividends, and options premiums with its secondary objective being capital appreciation. Under normal market conditions, the company invests majority of its assets in securities of companies principally engaged in the natural resources and gold industries, and also engages in writing covered call options on the underlying equity securities. Its portfolio consists of securities from different sectors such as metals and mining, energy and energy services, specialty chemicals, agriculture, healthcare, machinery, food and beverage, and others.